CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Feb. 03, 2018	Jan. 28, 2017	Jan. 30, 2016
Operating Activities
Net loss	$ (21,597,000)	$ (32,760,000)	$ (4,483,000)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	17,592,000	18,032,000	17,231,000
Stock-based compensation expense	1,154,000	1,801,000	2,784,000
Loss on impairment of long-lived assets	5,775,000	2,388,000	1,662,000
Loss on disposal of assets	349,000	272,000	193,000
Loss on extinguishment of debt	1,542,000
Grow NJ award benefit	422,000	349,000	(3,600,000)
Deferred income tax provision		24,614,000	2,020,000
Amortization of deferred financing costs	487,000	328,000	166,000
Decrease (increase) in:
Trade receivables	(1,009,000)	4,471,000	(951,000)
Inventories	(2,216,000)	3,469,000	3,250,000
Prepaid expenses and other current assets	(1,990,000)	328,000	3,194,000
Other non-current assets	14,000	37,000	(178,000)
(Decrease) increase in:
Accounts payable, accrued expenses and other current liabilities	8,565,000	(11,593,000)	(3,675,000)
Deferred rent and other non-current liabilities	(219,000)	(1,025,000)	(1,519,000)
Net cash provided by operating activities	8,869,000	10,711,000	16,094,000
Investing Activities
Capital expenditures	(6,649,000)	(12,690,000)	(29,272,000)
Proceeds from sale of property, plant and equipment		2,000	35,000
Additions to intangible assets	(18,000)	(97,000)	(163,000)
Net cash used in investing activities	(6,667,000)	(12,785,000)	(29,400,000)
Financing Activities
Increase (decrease) in cash overdrafts	5,116,000	681,000	(277,000)
Increase (decrease) in line of credit borrowings	3,400,000	(23,800,000)	28,400,000
Proceeds from long-term debt	25,901,000	32,000,000
Repayment of long-term debt	(34,382,000)	(4,498,000)	(2,801,000)
Deferred financing costs paid	(3,406,000)	(1,519,000)	(157,000)
Withholding taxes on stock-based compensation paid in connection with repurchase of common stock	(57,000)	(54,000)	(127,000)
Cash dividends paid	0	0	(11,026,000)
Proceeds from exercise of stock options		6,000	69,000
Net cash (used in) provided by financing activities	(3,428,000)	2,816,000	14,081,000
Effect of exchange rate changes on cash and cash equivalents	2,000	1,000	(8,000)
Net (Decrease) Increase in Cash and Cash Equivalents	(1,224,000)	743,000	767,000
Cash and Cash Equivalents, Beginning of Period	2,859,000	2,116,000	1,349,000
Cash and Cash Equivalents, End of Period	$ 1,635,000	$ 2,859,000	$ 2,116,000